The National Healthcare Security Administration releases the results of the expert evaluation phase of the declaration of drugs that have passed the formal review of the adjustment of the 2025 national basic medical insurance directory and the commercial insurance innovative drug directory.

The National Medical Insurance Administration announced the interim results of the expert review stage of the application drugs for the form examination of the adjustment of the National Basic Medical Insurance Catalog and Commercial Insurance Innovative Drug Catalog for 2025. Relevant applicant companies can log on to the National Medical Insurance Service Platform to check the review results. For drugs with expert review results of "proposed simplified renewal," "proposed renegotiation renewal," "proposed negotiation addition," "proposed competitive bidding addition," and "proposed price negotiation," related companies should download the corresponding "confirmation letter template" in the "Catalog Adjustment Module," fill it out as required, affix the official seal, and upload it to the "Catalog Adjustment Module" by 12:00 on September 23, 2025. The original document should also be sent to the National Medical Insurance Administration on the same day.